• יו"ר: דר' מאיר מי-זהב
  • גזבר: דר' רונן בר-יוסף
  • עורך האתר: דר' אופיר בר-און
  • חברי ועד: פרופ׳ אלי פיקאר (מזכיר)
  • פרופ׳ אביב גולדברט
  • דר' מורן לביא
  • פרופ׳ מאלנה כהן-סימברקנו
  • דר׳ פאהד חכים
Conferences and Presentations

The Yearly CF Meeting - October 2017

כנס CF שנתי | קיסריה | אוקטובר 2017

ריאות (אילוסטרציה)
ריאות (אילוסטרציה)

Bronchodilators and Cough in Cystic Fibrosis. Dr. Moshe Ashkenazi

Barriers To Newborn Screening for CF in Israel, Prof. Hannah Blau

Aspergillus - Bystander or Intruder, Dr. Malena Cohen-Cymberknoh

Antisense Oligonucleotide Splicing Modulation, A Novel Therapeutic Approach for CF, Prof. Batsheva Kerem

Alidornase alfa, Actin Inhibition Resistance DNase, In vitro and Ex vivo Efficacy and Delivery, Dr. Yoseph Shaaltiel

Advanced Lung Support – New Devices New Strategies, Iris Eisenstadt

Adherence, Why My Patients Don’t Listen to Me, Dr. Peter Mogayzel

Coaching the CF patient, Impact on Employment and Career Decisions, Mery Fasja

CF Medcare App, Maximising Adherence in the Digital Era, Edwina Landau

Burkholderia Cepacia In CF, Dr. Galit Livnat-Levanon

Israeli CF Database 2015, Dr. Meir Mei-Zahav

Iron Deficiency In Cystic Fibrosis, Dana Serfaty

Fertility and Pregnancy in CF, Dr. Michal Shteinberg

Fecal Calprotectin in CF Patients During Respiratory Exacerbations, Zeev Schnapp

EvoYon, Computational Discovery of CF Mutation Specific Drugs, Ori Inbar

Exacerbation Therapy, What We Know, What We Don't, Dr. Peter Mogayzel

Ethical and Social Aspects of Treating CF Patients Throughout the Course of Life, Danit Press

Current And Long Term Safety Data With Innovative And Future CF Treatments, Prof. Hannah Blau

Continuous vs Intermittent Inhaled Antibiotic Therapy in CF, Dr. Michal Gur

Ivacaftor, Dr. Alex Gileles-Hillel

Pseudomonas aeruginosa and Iron, Hila Alterovich

Predicting CFTR Modulator Clinical Efficacy by Pre-Clinical Biomarkers, Dr. Isabelle Sermet

Physiotherapy - Circle of Life, Hadas Mantin + Einav Manor

Phase IIa Clinical Trial Results with Alidornase Alfa for the Treatment of CF, Prof. Lea Bentur

Neonatal Screening in France, Dr. Isabelle Sermet

Long Term Effect of Orkambi on dF508 Homozygous in Israel, Dr. Dario Prais

Living With A Chronic Disease, Tomer Israeli

Treating and Coping with Uncooperative Patients, Sandra Eliyahu

Translational Read-Through of CFTR Nonsense Mutations, Pedro Huertas, Eloxx Pharmaceuticals

The Role of CPET in Assessing Lung Disease in CF, Dr. Meir Mei-Zahav

The Diagnosis of CF in 2017, Prof. Michael Wilschanski

Strengthening the Pelvic Floor for People with Cystic Fibrosis, Hadas Mantin

נושאים קשורים:  Conferences and Presentations
תגובות